Sage Capital Advisors’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
Other funds holding PFE
Sage Capital Advisors's PFE Position: Q3 2021 in Review
Sage Capital Advisors sold out of Pfizer (PFE) in Q3 2021, closing a stake of 43,027 shares — an estimated $1.76M sold.
Sage Capital Advisors first reported a position in PFE in Q2 2017 and held it in 17 quarters. The position peaked at $3.25M in Q3 2018. 2,803 funds tracked by Wall St. Rank hold PFE as of Q3 2021.
- Sage Capital Advisors reported no remaining Pfizer position as of Q3 2021 after selling out during the quarter.
- Sage Capital Advisors sold 43,027 Pfizer shares in Q3 2021, an estimated $1.76M.
- Sage Capital Advisors first reported a position in Pfizer in Q2 2017 and held it in 17 quarters.
- Sage Capital Advisors's Pfizer position peaked at $3.25M in Q3 2018.
- 2,803 funds tracked by Wall St. Rank held Pfizer as of Q3 2021.
Based on Sage Capital Advisors's 13F filing for Q3 2021, filed 26 Oct 2021.